Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell TransplantationDavid M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Transfusion|October 15, 2013
Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centersChitra Hosing, Rima M Saliba, Nelson Hamerschlak, et al.
Haematologica|August 8, 2015
Better allele-level matching improves transplant-related mortality after double cord blood transplantationBetül Oran, Kai Cao, Rima M Saliba, et al.
Cancer|March 4, 2020
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitorsBetül Oran, Guillermo Garcia-Manero, Rima M Saliba, et al.
European Journal of Immunology|April 13, 2018
Leishmania amazonensis downregulates macrophage iNOS expression via Histone Deacetylase 1 (HDAC1): a novel parasite evasion mechanismTeresa C Calegari-Silva, Áislan C Vivarini, Renata de M S Pereira, et al.
Transplantation and Cellular Therapy|December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor SelectionRohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
Haematologica|April 23, 2010
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor typeLeandro de Padua Silva, Poliana A Patah, Rima M Saliba, et al.
Acta Haematologica|July 1, 2020
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid LeukemiaAmanda L Olson, Rima M Saliba, Betul Oran, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Leukemia & Lymphoma|October 13, 2011
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplantStefan O Ciurea, Rima M Saliba, Nelson Hamerschlak, et al.
Pageof 16